369 Multiple myeloma and low risk MDS. Unique treatment: Lenalidomide
| Autor: | De Miguel Llorente, D., Golbano, N., Roman, I. López San, Morales, D., Arbeteta, J., Subirá, D., Herrero, S., Diaz, M., Pinedo, B. |
|---|---|
| Zdroj: | In Leukemia Research 2011 35 Supplement 1:S147-S147 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect